Precision in treatment evaluation: importance of minimal clinically important differences (MCIDs) of outcome measures for autoimmune blistering diseases

Autoimmune blistering diseases (AIBDs) comprise a group of rare conditions marked by autoantibodies that specifically target intercellular adhesion molecules. Despite the progress made in comprehending the disease and the increasing number of treatment options available, there is still no definitive...

Descripción completa

Detalles Bibliográficos
Autores principales: Tseng, Henry, Stone, Corey, Murrell, Dédée F.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10560849/
https://www.ncbi.nlm.nih.gov/pubmed/37818362
http://dx.doi.org/10.3389/fimmu.2023.1243581

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10560849/
https://www.ncbi.nlm.nih.gov/pubmed/37818362
http://dx.doi.org/10.3389/fimmu.2023.1243581

Ejemplares similares